Sandoz

Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Novartis
rheumatoid arthritis
generics
Sandoz
Amgen
Enbrel
JNJ
Remicade
AbbVie
Humira
Flag link:
Biogen aims to block Tecfidera generics with flurry of lawsuits
Biogen aims to block Tecfidera generics with flurry of lawsuits
Bizjournals.com
Biogen
Tecfidera
generics
MS
multiple sclerosis
Novartis
Sandoz
Mylan Labs
Flag link:
Novartis scores second biosimilar approval in two weeks
Novartis scores second biosimilar approval in two weeks
BioPharma Dive
Novartis
biosimilars
Enbrel
Europe
Sandoz
Erelzi
Roche
Rituxan
Flag link:
Novartis wins another biosimilar round with an OK for its Rituxan copycat
Novartis wins another biosimilar round with an OK for its Rituxan copycat
Endpoints
Novartis
biosimilars
Rituxan
Roche
Sandoz
Flag link:
Novartis pushes further into pain with Durect deal
Novartis pushes further into pain with Durect deal
BioPharma Dive
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
Flag link:
The Demise of the BPCIA Patent Dance?
The Demise of the BPCIA Patent Dance?
FDA Law Blog
BPCIA
patents
Genentech
Amgen
Sandoz
Avastin
Flag link:
In Amgen-Sandoz SCOTUS case, biosim makers lambaste ruling's 6-month exclusivity gift
In Amgen-Sandoz SCOTUS case, biosim makers lambaste ruling's 6-month exclusivity gift
Fierce Pharma
Amgen
Sandoz
Supreme Court
biosimilars
Flag link:
Amgen and the BPCIA Patent Dance – Redux
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
Flag link:
Amgen Fight Over Copies of Biotech Drugs Gets High Court Review
Amgen Fight Over Copies of Biotech Drugs Gets High Court Review
Bloomberg
Amgen
Supreme Court
Neupogen
Novartis
Sandoz
biosimilars
Flag link:
Novartis donates $10M in generics to global relief
Novartis donates $10M in generics to global relief
BioPharma Dive
Novartis
generics
philanthropy
Sandoz
Flag link:
Novartis May Be Too Generic
Novartis May Be Too Generic
TheStreet.com
Novartis
generics
patents
Sandoz
Flag link:
Generics creep in as Teva loses two Copaxone patents
Generics creep in as Teva loses two Copaxone patents
BioPharma Dive
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
generics
Glatopa
Novartis
Sandoz
Flag link:
Sandoz Enbrel biosim cruises at FDA panel, endangering key Amgen sales
Sandoz Enbrel biosim cruises at FDA panel, endangering key Amgen sales
Fierce Pharma
Sandoz
Novartis
FDA
advisory panels
biosimilars
Enbrel
Amgen
Flag link:
FDA, Sandoz Prevail at D.C. Circuit on Generic FUSILEV Approval
FDA, Sandoz Prevail at D.C. Circuit on Generic FUSILEV Approval
FDA Law Blog
FDA
Sandoz
Fusilev
generics
Flag link:
Novartis CEO eyes biosimilar plays in Asia that fit with Sandoz plans
Novartis CEO eyes biosimilar plays in Asia that fit with Sandoz plans
Fierce Pharma
Novartis
Pharma CEOs
Joe Jimenez
Asia
Sandoz
biosimilars
Flag link:
Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in
Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in
Fierce Pharma
Supreme Court
Sandoz
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Flag link:
Novartis finds buyer to save 270 jobs at German plant
Novartis finds buyer to save 270 jobs at German plant
Fierce Pharma
Novartis
Sandoz
layoffs
Germany
drug manufacturing
Flag link:
Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches
Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches
Fierce Pharma
Sandoz
generics
Supreme Court
exclusivity
biosimilars
Zarxio
Flag link:
Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision
Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision
FDA Law Blog
Sandoz
FDA
BPCIA
Amgen
Zarxio
Neupogen
Flag link:
EU agency accepts Sandoz application for pegfilgrastim biosimilar
EU agency accepts Sandoz application for pegfilgrastim biosimilar
Yahoo/Reuters
Europe
Sandoz
Novartis
biosimilars
pegfilgrastim
Neulasta
Flag link: